Lovenberg; Timothy W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lovenberg; Timothy W..The latest application filed is for "hexahydro-pyrrolo-isoquinoline compounds".
Company Profile
0.24.29
- Lovenberg; Timothy W. - San Diego CA
- Lovenberg; Timothy W - Carlsbad CA
- Lovenberg, Timothy W. - Carlsbad CA
Patent Activity
| Patent | Date |
|---|---|
| Hexahydro-pyrrolo-isoquinoline Compounds App 20120321559 - Apodaca; Richard ; et al. | 2012-12-20 |
| Hexahydro-pyrrolo-isoquinoline compounds Grant 8,273,762 - Apodaca , et al. September 25, 2 | 2012-09-25 |
| Methods of identifying modulators of GPR81 receptors Grant 8,148,056 - Liu , et al. April 3, 2 | 2012-04-03 |
| GPR81-Ligand complexes and their preparation and use App 20110104711 - Liu; Changlu ; et al. | 2011-05-05 |
| Aryl piperidine amides Grant 7,915,420 - Huang , et al. March 29, 2 | 2011-03-29 |
| Relaxin-3 chimeric polypeptides and their preparation and use Grant 7,893,197 - Bonaventure , et al. February 22, 2 | 2011-02-22 |
| Hexahydro-pyrrolo-isoquinoline Compounds App 20100240648 - Apodaca; Richard ; et al. | 2010-09-23 |
| Hexahydro-pyrrolo-isoquinoline compounds Grant 7,754,882 - Apodaca , et al. July 13, 2 | 2010-07-13 |
| Canine 5-hydroxytryptamine 2A and 2B receptor Grant 7,728,107 - Bonaventure , et al. June 1, 2 | 2010-06-01 |
| Method for identifying modulators of human orexin-2 receptor Grant 7,618,786 - Sutton , et al. November 17, 2 | 2009-11-17 |
| Octahydro-indolizine And Quinolizine And Hexahydro-pyrrolizines App 20090263322 - Apodaca; Richard ; et al. | 2009-10-22 |
| Non-peptidic Npy Y2 Receptor Inhibitors App 20080132540 - Carruthers; Nicholas I. ; et al. | 2008-06-05 |
| Canine 5-Hydroxytryptamine 2A and 2B Receptor Materials and Their Use App 20080131913 - Bonaventure; Pascal ; et al. | 2008-06-05 |
| Relaxin-3 Chimeric Polypeptides and Their Preparation and Use App 20080051336 - Bonaventure; Pascal ; et al. | 2008-02-28 |
| Aryl Piperidine Amides App 20080009521 - Huang; Charles Q. ; et al. | 2008-01-10 |
| Non-peptidic NPY Y2 receptor inhibitors Grant 7,317,025 - Carruthers , et al. January 8, 2 | 2008-01-08 |
| Aryl piperidine amides Grant 7,276,610 - Huang , et al. October 2, 2 | 2007-10-02 |
| 2-oxy, 2-amino, and 2-thio-imidazole compounds Grant 7,265,135 - Bogenstaetter , et al. September 4, 2 | 2007-09-04 |
| Methods of use of DNA encoding a human histamine receptor of the H3 subtype Grant 7,179,604 - Lovenberg , et al. February 20, 2 | 2007-02-20 |
| Hexahydro-pyrrolo-isoquinoline Compounds App 20060293316 - Apodaca; Richard ; et al. | 2006-12-28 |
| Histamine receptor H3 modified transgenic mice Grant 7,151,200 - Lovenberg , et al. December 19, 2 | 2006-12-19 |
| Relaxin3-gpcr135 complexes and their production and use App 20060188956 - Chen; Jingcai ; et al. | 2006-08-24 |
| Human histamine receptor of the H3 subtype Grant 7,049,401 - Lovenberg , et al. May 23, 2 | 2006-05-23 |
| Corticotropin-releasing factor.sub.2 receptors Grant 7,034,118 - Lovenberg , et al. April 25, 2 | 2006-04-25 |
| Histamine Receptor H3 Modified Transgenic Mice App 20060064766 - Lovenberg; Timothy W. ; et al. | 2006-03-23 |
| Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine App 20050288323 - Apodaca, Richard ; et al. | 2005-12-29 |
| Substituted 4-phenyl-[1,3]-dioxanes Grant 6,951,882 - Carruthers , et al. October 4, 2 | 2005-10-04 |
| Heterocyclic compounds App 20050085487 - Carruthers, Nicholas I. ; et al. | 2005-04-21 |
| Relaxin3-GPCR135 complexes and their production and use App 20050074814 - Chen, Jingcai ; et al. | 2005-04-07 |
| Non-peptidic NPY Y2 receptor inhibitors App 20050070534 - Carruthers, Nicholas I. ; et al. | 2005-03-31 |
| Complexes of GPCR142 and relaxin3 or INSL5, and their production and use App 20050059089 - Kuei, Chester ; et al. | 2005-03-17 |
| Aryl piperidine amides App 20050049239 - Huang, Charles Q. ; et al. | 2005-03-03 |
| Method of identifying compounds that modulate human histamine H3 receptor Grant 6,855,560 - Lovenberg , et al. February 15, 2 | 2005-02-15 |
| Heterocyclic compounds Grant 6,803,362 - Carruthers , et al. October 12, 2 | 2004-10-12 |
| Corticotropin-releasing factor2 receptors App 20040185533 - Lovenberg, Timothy W. ; et al. | 2004-09-23 |
| Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine App 20040167336 - Apodaca, Richard ; et al. | 2004-08-26 |
| DNA encoding a human histamine receptor of the H3 subtype App 20040156845 - Lovenberg, Timothy W. ; et al. | 2004-08-12 |
| Heterocyclic compounds App 20040147577 - Bogenstaetter, Michael ; et al. | 2004-07-29 |
| Substituted 4-phenyl-[1,3]-dioxanes App 20040147593 - Carruthers, Nicholas I. ; et al. | 2004-07-29 |
| Corticotropin-releasing factor2 receptors Grant 6,723,841 - Lovenberg , et al. April 20, 2 | 2004-04-20 |
| Heterocyclic compounds App 20030207893 - Carruthers, Nicholas I. ; et al. | 2003-11-06 |
| Pyrazole carboxamides useful for the treatment of obesity and other disorders Grant 6,511,998 - Kordik , et al. January 28, 2 | 2003-01-28 |
| Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine App 20030013733 - Apodaca, Richard ; et al. | 2003-01-16 |
| Heterocyclic compounds App 20020198237 - Bogenstaetter, Michael ; et al. | 2002-12-26 |
| DNA encoding a human histamine receptor of the H3 subtype Grant 6,437,100 - Lovenberg , et al. August 20, 2 | 2002-08-20 |
| Corticotropin-releasing factor2 receptors App 20020077468 - Lovenberg, Timothy W. ; et al. | 2002-06-20 |
| Amino pyrazole derivatives useful for the treatment of obesity and other disorders App 20020065289 - Kordik, Cheryl P. ; et al. | 2002-05-30 |
| Pyrazole carboxamides useful for the treatment of obesity and other disorders App 20020058816 - Kordik, Cheryl P. ; et al. | 2002-05-16 |
| Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists App 20010044439 - Carruthers, Nicholas I. ; et al. | 2001-11-22 |
| Pyrazole carboxamides useful for the treatment of obesity and other disorders Grant 6,291,476 - Kordik , et al. September 18, 2 | 2001-09-18 |
| N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders Grant 6,140,354 - Dax , et al. October 31, 2 | 2000-10-31 |
| DNA encoding serotonin receptors Grant 5,968,817 - Sutcliffe , et al. October 19, 1 | 1999-10-19 |
| Isolated nucleic acid encoding corticotropin-releasing factor.sub.2 receptors Grant 5,786,203 - Lovenberg , et al. July 28, 1 | 1998-07-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 